Skye Bioscience (SKYE)
OTHER OTC:SKYE
US Market

Skye Bioscience (SKYE) Stock Price & Analysis

76 Followers

SKYE Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.01 - $0.06
Previous Close$0.01
Volume315.13K
Average Volume (3M)1.23M
Market Cap
$13.41M
Enterprise Value$10.97M
Total Cash (Recent Filing)$2.67M
Total Debt (Recent Filing)$239.89K
Price to Earnings (P/E)-0.4
Beta0.24
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding971,549,608
10 Day Avg. Volume829,963
30 Day Avg. Volume1,230,772
Standard Deviation0.31
R-Squared0.00573
Alpha-0.00806
Financial Highlights & Ratios
Price to Book (P/B)-0.26
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.55
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

SKYE FAQ

What was Skye Bioscience’s price range in the past 12 months?
Skye Bioscience lowest stock price was $0.01 and its highest was $0.06 in the past 12 months.
    What is Skye Bioscience’s market cap?
    Currently, no data Available
    When is Skye Bioscience’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Skye Bioscience’s earnings last quarter?
    Currently, no data Available
    Is Skye Bioscience overvalued?
    According to Wall Street analysts Skye Bioscience’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Skye Bioscience pay dividends?
      Skye Bioscience does not currently pay dividends.
      What is Skye Bioscience’s EPS estimate?
      Skye Bioscience’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Skye Bioscience have?
      Skye Bioscience has 971,549,600 shares outstanding.
        What happened to Skye Bioscience’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Skye Bioscience?
        Currently, no hedge funds are holding shares in SKYE

        ---

        Skye Bioscience Stock Smart Score

        N/A
        Not Ranked
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Technicals

        SMA
        Negative
        20 days / 200 days
        Momentum
        -66.66%
        12-Months-Change

        Fundamentals

        Return on Equity
        Trailing 12-Months
        Asset Growth
        -36.39%
        Trailing 12-Months
        This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
        Learn more about TipRanks Smart Score

        Company Description

        Skye Bioscience

        Emerald Bioscience, Inc. engages on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids. The company was founded on March 16, 2011 and is headquartered in Long Beach, CA.

        ---

        Forecast EPS vs Actual EPS

        Currently, no data available
        Please return soon. This page is being updated.

        Similar Stocks
        Company
        Price & Change
        Follow
        Acasti Pharma
        Aethlon Medical
        Aptose Biosciences
        BioCryst

        Popular Stocks

        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis